# EDGAR Filing Document

**Accession Number:** 0002023016
**File Stem:** 0001104659-25-059385
**Filing Date:** 2025-6
**Character Count:** 2507
**Document Hash:** 3dece00152bbd022be573f610075e220
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-25-059385.hdr.sgml**: 20250613

**ACCESSION NUMBER**: 0001104659-25-059385

**CONFORMED SUBMISSION TYPE**: 253G2

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250613

**DATE AS OF CHANGE**: 20250613

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Global Health Solutions, Inc
- **CENTRAL INDEX KEY:** 0002023016
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 320456090
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 253G2
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 024-12562
- **FILM NUMBER:** 251046936

**BUSINESS ADDRESS:**
- **STREET 1:** 250 NORTH WESTLAKE BLVD.
- **STREET 2:** #210
- **CITY:** WESTLAKE VILLAGE
- **STATE:** CA
- **ZIP:** 91362
- **BUSINESS PHONE:** 8185644011

**MAIL ADDRESS:**
- **STREET 1:** 250 N. WESTLAKE BLVD.
- **STREET 2:** #210
- **CITY:** WESTLAKE VILLAGE
- **STATE:** CA
- **ZIP:** 91362

**Filed pursuant to Rule 253(g)(2)**

**File No. 024-12562**

**SUPPLMENT DATED JUNE 13, 2025**

**GLOBAL HEALTH SOLUTIONS, INC. , dba Turn Therapeutics**

**EXPLANATORY NOTE**

This document supplements, and should be read in conjunction with, the offering statement on Form 1-A filed by Global Health Solutions, Inc. (the "Company") and amendments and supplements thereto. The offering statement was qualified by the U.S. Securities and Exchange Commission on March 31, 2025. Unless otherwise defined in this supplement, capitalized terms used in this supplement shall have the same meanings as set forth in the Offering Circular.

The Offering Circular is available [here](https://www.sec.gov/Archives/edgar/data/2023016/000110465925030828/tm254643d10_253g2.htm).

The purpose of this supplement is to announce the following change to the offering statement and any supplements, effective immediately:

**Offering Termination Date**

The purpose of this supplement is to announce that the Regulation A offering conducted by the Company will terminate on June 27, 2025 (the "Termination Date"). No further subscriptions will be accepted after 11:59 pm PT on June 27, 2025. Subscriptions in the offering will be accepted up to that time and processed as promptly as possible. None of the terms of the offering have been changed. In addition, as described in the Offering Circular, the Company retains the right to continue the offering beyond the Termination Date, in its sole discretion.